The demand for prescription drugs as a function of cost-sharing
Dados Bibliográficos
| ID | 4596090 |
|---|---|
| Autores | Arleen Leibowitz (0000-0001-6970-0564, RAND Corporation), Willard G Manning (RAND Corporation), Joseph P Newhouse (0000-0001-5837-3203, RAND Corporation) |
| Ano | 1985 |
| Volume | 21 |
| Fascículo | 10 |
| Páginas | 1063-1069 |
| Data de publicação | 1985-01-01 |
| Peer Reviewed | Sim |
| Open Access | Sim |
| Tipo | ARTICLE |
| Periódico | Social Science & Medicine (JOURNAL) |
| Identificadores do periódico | ISSN: 0277-9536 • E-ISSN: 1873-5347 |
| Editora | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/0277-9536(85)90161-3 |
| PMID | 3936186 |
| OpenAlex | W1980314306 |
| Idioma | EN |
| Citações recebidas | 35 |
| Referências citadas | 10 |
Actuarial science · Business · Cost sharing · Economic growth · Economics · Environmental health · Family medicine · Health care · Health insurance · Medical prescription · Per capita · Population · Prescription drug · Health Systems, Economic Evaluations, Quality of Life · Healthcare Policy and Management · Medicine · Nursing · Pharmaceutical Economics and Policy · Pharmacology · Pharmacy
Substitution Between Prescribed and Over-the-Counter Medications
Are Prescribed and Over-the-Counter Medicines Economic Substitutes
The Findings of the Rand Health Insurance Experiment??? A Response to Welch et al
Gender and Psychotropic Drug Use
Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons
Prescription Drug Cost Sharing
Consumer out-of-pocket spending for pharmaceuticals in Kazakhstan
Physician altruism and moral hazard
Illness Experience and Therapeutic Choice
The seed of abundance and misery
What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries
A conceptually based approach to understanding chronically ill patients’ responses to medication cost pressures
Take-up of Medicare Part D
National Pharmacare, Reference-Based Pricing, and Drug R&D
Overtreatment and benevolent provider moral hazard
Illness Experience and Therapeutic Choice
Ethnic differences in access to prescription medication because of cost in New Zealand
Impact of a Pharmacy Copayment Increase on Medication Use in the Military Health System
Coverage and Use of Prescription Drugs in Nursing Homes
Prescription Drug Coverage, Health, and Medication Acquisition Among Seniors With One or More Chronic Conditions
The Effect of Increased Prescription Drug Cost-Sharing on Medical Care Utilization and Expenses of Elderly Health Maintenance Organization Members
On Becoming 65 in Ontario
Effect of Increased Copayments on Pharmacy Use in the Department of Veterans Affairs
The Population's Use of Pharmaceuticals
Ability to Pay and the Decision to Medicate
The Impact of Implementing a More Restrictive Prescription Limit on Medicaid Recipients
Transitioning the Second-Generation Antihistamines to Over-the-Counter Status
The Insurance Effect on Prescription Drug Expenditures Among the Elderly
Clinically Sensitive Cost-Sharing for Prescription Drugs
Patient, Physician, and Payment Predictors of Statin Adherence
The influence of prescription drug insurance on psychotropic and non-psychotropic drug utilization in Canada
Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals
Moral hazard and prescription medicine use in Australia-the patient perspective
Charging for health care
Compensating behaviors, regret, and heterogeneity in the dynamics of smoking behavior
| Obras citantes distintas | 35 |
|---|---|
| Citações por ano | 0,9 |
| Intervalo de citações | 1987 - 2025 (39) |
| Velocidade de citação | recent |
| Altamente citado | Não |
| Tipos de citação | Neutras: 31 |